David Bruhlmann

Sure, here is an article about inventor David Bruhlmann:

Title: The Innovative Work of David Bruhlmann in Modulating Protein Glycosylation Profiles

Introduction:

David Bruhlmann, a talented inventor based in Lausanne, Switzerland, has made significant strides in the field of biotechnology. With a total of 4 patents to his name, he is renowned for his groundbreaking methods in modulating protein glycosylation profiles.

Latest Patents:

Bruhlmann's latest patents include "Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin" and "Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose." These inventions revolutionize the modulation of glycosylation profiles in recombinant proteins expressed by mammalian host cells during the cell culture process, enhancing their therapeutic potential.

Career Highlights:

David Bruhlmann is a key figure at Ares Trading S.A., a biotechnology company at the forefront of innovation in protein engineering. His expertise in glycosylation modulation has paved the way for novel biopharmaceutical developments, positioning him as a leader in the industry.

Collaborations:

Bruhlmann collaborates closely with esteemed colleagues such as Martin Jordan and Herve Broly, who share his passion for advancing biotechnological solutions. Together, they drive forward pioneering research aimed at optimizing protein expression and functionality.

Conclusion:

In conclusion, David Bruhlmann's inventive prowess in modulating protein glycosylation profiles underscores his commitment to pushing the boundaries of biotechnological innovation. His contributions have the potential to revolutionize the biopharmaceutical landscape, offering new avenues for the development of next-generation therapeutic proteins.